Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Can Big Genomic Data Reveal the Fundamental Units of the Brain?

    Jan 20, 2016, 11:10 AM by Michael Croft
    Bio-IT World | An ambitious new study from the Allen Institute for Brain Science illustrates how new methods for isolating and studying single cells, combined with massive RNA sequencing data, are changing the way neuroscientists think about the variety and organization of cells in the brain.
    Full story
  • CSM Announces Two Key Executive Promotions

    Jan 19, 2016, 10:37 AM by Michael Croft
    FARGO, ND - Jan 20, 2016 - CSM, a leading clinical trial supply company, today announced that Brian Swites was promoted to Vice President of Operations and Bob Albanese was named Senior Vice President of Strategic Development
    Full story
  • AAAS Selects Danforth Center Principal Investigator to Serve as Chair-Elect for the Biological Sciences

    Jan 19, 2016, 09:59 AM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Jan 19, 2016 - The Donald Danforth Plant Science Center announced Elizabeth (Toby) Kellogg , Ph.D., member and principal investigator was selected by the American Association for the Advancement of Science  (AAAS) to serve as chair-elect for the Biological Sciences Section beginning in late February this year
    Full story
  • Aridhia’s data platform used in major £64m European research collaboration to tackle Alzheimer’s dementia

    Jan 19, 2016, 05:43 AM by Michael Croft
    EDINBURGH, UNITED KINGDOM - Jan 19, 2016 - Aridhia has today announced that it is among 36 organisations behind a ground-breaking Innovative Medicines Initiative research programme that aims to build a platform for efficient testing of innovative treatments for the prevention of Alzheimer’s dementia
    Full story
  • The Muscular Dystrophy Patient and Olympic Medalist with the Same Genetic Disorder

    Jan 18, 2016, 11:08 AM by Michael Croft
    ProPublica | David Epstein tells the story of how a woman whose muscles disappeared discovered, through years of dogged research, that she shared a disease with a muscle-bound Olympic athlete.
    Full story
  • Congenica achieves ISO 27001 and NHS IGT accreditation

    Jan 18, 2016, 10:42 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Jan 18, 2016 - Congenica, a world leading developer of genome analysis technologies, places the highest importance on data security and information governance and is therefore pleased to announce that it has successfully achieved two major milestones: ISO 27001 accreditation and compliance with the NHS Information Governance Toolkit (IGT)
    Full story
  • Titian Software launches Mosaic SampleBankTM to offer a simple route to sample management best practice

    Jan 18, 2016, 10:06 AM by Michael Croft
    LONDON, UK - Jan 18, 2016 - Titian (www.titian.co.uk) is launching Mosaic SampleBank™ to offer the benefits of sample management best practice, gained from collaborating with big pharma companies, in a format that is cost-effective and rapid for other institutions to deploy
    Full story
  • Potentially transformative therapy for pulmonary arterial hypertension to be progressed by Morphogen-IX

    Jan 18, 2016, 06:01 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Jan 18, 2016 - Morphogen-IX, a new Cambridge-based biotech company, has gained seed funding to develop a new treatment for pulmonary arterial hypertension (PAH) that directly targets the major pathway implicated in human genetic studies
    Full story
  • NIH Launches Centers for Common Disease Genomics

    Jan 14, 2016, 14:25 PM by Michael Croft
    Bio-IT World News Brief | With funding from the National Human Genome Research Institute, and the National Heart, Lung, and Blood Institute, four new Centers for Common Disease Genomics could receive up to $260 million over four years.
    Full story
  • Intellia Therapeutics Forms New Division eXtellia for Joint Programs with Novartis

    Jan 14, 2016, 10:50 AM by Michael Croft
    Bio-IT World News Brief | Intellia Therapeutics, one of three major companies developing drugs based on CRISPR-Cas9 gene editing technology, has announced that its ex vivo programs will now be pursued in a new division of the company called eXtellia Therapeutics.
    Full story
  • The Danforth Center Collaborates With the University of Illinois to Develop More Efficient Crops that Will Use Less Fertilizer to Produce More Yield

    Jan 13, 2016, 12:51 PM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Jan 13, 2016 - The Donald Danforth Plant Science Center announced it has received a three-year grant from the U.S. Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) to enhance nitrogen use efficiency (NUE)
    Full story
  • Pathway Genomics, IBM Health App

    Jan 12, 2016, 15:05 PM by Michael Croft
    ZDNet | Pathway Genomics last week announced that the app the company has been developing with IBM Watson is now in closed alpha release.
    Full story
  • Jolly Jay Flatley Ushers in Another Big Year for Illumina

    Jan 12, 2016, 14:40 PM by Michael Croft
    Bio-IT World | The JP Morgan Healthcare Conference comes but once a year. Now it’s here, now it’s here, and Illumina CEO Jay Flatley has honored his seasonal tradition by releasing a new next-generation sequencer in his address to investors.
    Full story
  • Certara Launches a Strategic Drug Development Consulting Company in China

    Jan 12, 2016, 09:44 AM by Michael Croft
    PRINCETON, NJ - Jan 12, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced the launch of Certara Strategic Consulting China in Shanghai
    Full story
  • Illumina Spinoff GRAIL to Trial Liquid Biopsies for Early Detection of Cancer

    Jan 11, 2016, 11:10 AM by Michael Croft
    Bio-IT World | Illumina, the dominant manufacturer of DNA sequencing technology, has formed a spinoff company called GRAIL to experiment with a pan-cancer blood test, an undertaking for which hundreds of thousands of patients may be enrolled in clinical studies.
    Full story
  • You're Probably Not Mostly Microbes

    Jan 8, 2016, 14:19 PM by Michael Croft
    The Atlantic | A new study revises the most famous "fact" about the microbiome: that microbes outnumber human cells in the body ten to one.
    Full story
  • BioMérieux and Illumina Use Whole Genome Sequencing to Monitor Hospital Infections

    Jan 8, 2016, 13:00 PM by Michael Croft
    Bio-IT World | In partnership with Illumina, multinational diagnostics company bioMérieux has launched EpiSeq, the first commercial system to monitor outbreaks in hospitals by sequencing and analyzing the whole genomes of bacteria.
    Full story
  • Moderna Signs Deal with Contract Researcher to Bring mRNA Therapies Into Clinical Trials

    Jan 8, 2016, 10:12 AM by Michael Croft
    FierceBiotech | Moderna Therapeutics, a high-profile private biotech with scores of preclinical projects, is finally moving toward human trials, recruiting one of the world's largest CROs to help get its much-hyped pipeline moving.
    Full story
  • A Precision Medicine Blitz in China

    Jan 6, 2016, 09:38 AM by Michael Croft
    Nature News | A new push by the Chinese government for research in genomic health is expected to dwarf the U.S. Precision Medicine Initiative in both scale and funding, although China's shortage of physicians and drug development capacity may make it hard to capitalize on new discoveries.
    Full story
  • Editas Medicine Files for CRISPR Technology's First IPO

    Jan 5, 2016, 12:15 PM by Michael Croft
    Bio-IT World | Still facing a looming patent dispute over its most basic intellectual property, Editas Medicine registered with the SEC for an initial public offering this week, making it the first therapeutics company based on CRISPR-Cas9 gene editing to go public.
    Full story
  • «
  • 351
  • 352
  • 353
  • 354
  • 355
  • 356
  • 357
  • 358 (current)
  • 359
  • 360
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy